Drug Interactions between Hemetab and Multaq
This report displays the potential drug interactions for the following 2 drugs:
- Hemetab (multivitamin with iron)
- Multaq (dronedarone)
Interactions between your drugs
No interactions were found between Hemetab and Multaq. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
A total of 87 drugs are known to interact with Hemetab.
- Hemetab is in the following drug classes: iron products, vitamin and mineral combinations.
- Hemetab is used to treat the following conditions:
- Multaq is in the drug class group III antiarrhythmics.
- Multaq is used to treat the following conditions:
Drug and food interactions
Applies to: Multaq (dronedarone)
Do not consume grapefruit or grapefruit juice during treatment with dronedarone unless directed otherwise by your doctor. Grapefruit juice can increase the blood levels of dronedarone to dangerous levels. This may increase the risk of an irregular heart rhythm that may be serious and potentially life-threatening, although it is a relatively rare side effect. You may be more susceptible if you have a heart condition called congenital long QT syndrome, other cardiac diseases, conduction abnormalities, or electrolyte disturbances (for example, magnesium or potassium loss due to severe or prolonged diarrhea or vomiting). Talk to your doctor if you have any questions or concerns. You should seek immediate medical attention if you develop sudden dizziness, lightheadedness, fainting, shortness of breath, or heart palpitations during treatment. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
multivitamin with iron food
Applies to: Hemetab (multivitamin with iron)
Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.